Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. more
Time Frame | NPCE | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.22% | -2.27% | -0.57% |
1-Month Return | 20.55% | -3.96% | 1.21% |
3-Month Return | 48.45% | -9.7% | 7.57% |
6-Month Return | 65.12% | -3.37% | 11.45% |
1-Year Return | 34.35% | 3.71% | 28.48% |
3-Year Return | 12.44% | 3.8% | 29.52% |
5-Year Return | -55.81% | 39.78% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 36.97M | 41.14M | 45.18M | 45.52M | 65.42M | [{"date":"2019-12-31","value":56.51,"profit":true},{"date":"2020-12-31","value":62.88,"profit":true},{"date":"2021-12-31","value":69.06,"profit":true},{"date":"2022-12-31","value":69.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 10.51M | 10.87M | 11.75M | 13.03M | 17.30M | [{"date":"2019-12-31","value":60.74,"profit":true},{"date":"2020-12-31","value":62.81,"profit":true},{"date":"2021-12-31","value":67.91,"profit":true},{"date":"2022-12-31","value":75.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 26.46M | 30.27M | 33.44M | 32.49M | 48.12M | [{"date":"2019-12-31","value":54.99,"profit":true},{"date":"2020-12-31","value":62.91,"profit":true},{"date":"2021-12-31","value":69.48,"profit":true},{"date":"2022-12-31","value":67.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 71.58% | 73.59% | 74.00% | 71.38% | 73.56% | [{"date":"2019-12-31","value":96.73,"profit":true},{"date":"2020-12-31","value":99.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.46,"profit":true},{"date":"2023-12-31","value":99.4,"profit":true}] |
Operating Expenses | 48.49M | 43.32M | 57.17M | 73.29M | 75.30M | [{"date":"2019-12-31","value":64.41,"profit":true},{"date":"2020-12-31","value":57.54,"profit":true},{"date":"2021-12-31","value":75.93,"profit":true},{"date":"2022-12-31","value":97.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (22.03M) | (13.05M) | (23.74M) | (40.79M) | (27.17M) | [{"date":"2019-12-31","value":-2203100000,"profit":false},{"date":"2020-12-31","value":-1305100000,"profit":false},{"date":"2021-12-31","value":-2373700000,"profit":false},{"date":"2022-12-31","value":-4079400000,"profit":false},{"date":"2023-12-31","value":-2717400000,"profit":false}] |
Total Non-Operating Income/Expense | (17.17M) | (22.67M) | (19.30M) | (12.24M) | (11.25M) | [{"date":"2019-12-31","value":-1716600000,"profit":false},{"date":"2020-12-31","value":-2267200000,"profit":false},{"date":"2021-12-31","value":-1930500000,"profit":false},{"date":"2022-12-31","value":-1223900000,"profit":false},{"date":"2023-12-31","value":-1124900000,"profit":false}] |
Pre-Tax Income | (29.97M) | (24.28M) | (36.08M) | (47.08M) | (32.96M) | [{"date":"2019-12-31","value":-2997300000,"profit":false},{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}] |
Income Taxes | 10.77M | 11.70M | 2.03M | 6.29M | 1.44M | [{"date":"2019-12-31","value":91.99,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":17.34,"profit":true},{"date":"2022-12-31","value":53.73,"profit":true},{"date":"2023-12-31","value":12.28,"profit":true}] |
Income After Taxes | (40.74M) | (35.98M) | (38.11M) | (53.37M) | (34.39M) | [{"date":"2019-12-31","value":-4074000000,"profit":false},{"date":"2020-12-31","value":-3598200000,"profit":false},{"date":"2021-12-31","value":-3810900000,"profit":false},{"date":"2022-12-31","value":-5337000000,"profit":false},{"date":"2023-12-31","value":-3439310500,"profit":false}] |
Income From Continuous Operations | (29.97M) | (24.28M) | (36.08M) | (47.08M) | (32.96M) | [{"date":"2019-12-31","value":-2997300000,"profit":false},{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (40.74M) | (35.98M) | (38.11M) | (53.37M) | (32.96M) | [{"date":"2019-12-31","value":-4074000000,"profit":false},{"date":"2020-12-31","value":-3598200000,"profit":false},{"date":"2021-12-31","value":-3810900000,"profit":false},{"date":"2022-12-31","value":-5337000000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}] |
EPS (Diluted) | - | (0.17) | (33.99) | (1.92) | (1.28) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-17,"profit":false},{"date":"2021-12-31","value":-3399,"profit":false},{"date":"2022-12-31","value":-192,"profit":false},{"date":"2023-12-31","value":-128,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NPCE | |
---|---|
Cash Ratio | 3.84 |
Current Ratio | 5.59 |
Quick Ratio | 4.77 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NPCE | |
---|---|
ROA (LTM) | -14.74% |
ROE (LTM) | -214.55% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NPCE | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.90 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.10 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NPCE | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 4.31 |
P/B | 33.52 |
Price/FCF | NM |
EV/R | 4.52 |
EV/Ebitda | NM |
Neuropace Inc (NPCE) share price today is $11.03
Yes, Indians can buy shares of Neuropace Inc (NPCE) on Vested. To buy Neuropace Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NPCE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Neuropace Inc (NPCE) via the Vested app. You can start investing in Neuropace Inc (NPCE) with a minimum investment of $1.
You can invest in shares of Neuropace Inc (NPCE) via Vested in three simple steps:
The 52-week high price of Neuropace Inc (NPCE) is $18.15. The 52-week low price of Neuropace Inc (NPCE) is $5.45.
The price-to-earnings (P/E) ratio of Neuropace Inc (NPCE) is
The price-to-book (P/B) ratio of Neuropace Inc (NPCE) is 33.52
The dividend yield of Neuropace Inc (NPCE) is 0.00%
The market capitalization of Neuropace Inc (NPCE) is $330.72M
The stock symbol (or ticker) of Neuropace Inc is NPCE